Exoskeleton Gait Training for Stroke Recovery

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Recruiting N/A Interventional Study
Stroke Weakness of Extremities as Sequela of Stroke
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
University of Oklahoma · Other
Who this trial is looking for

This trial is looking for patients who have had a stroke and are in rehabilitation. Participants will try out a special training device that helps with walking to see if it improves their recovery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have had a stroke that is documented by medical imaging.
  • I am stable enough to take part in daily therapies.
  • I am able to stand on my own.
  • I can give informed consent and understand what the trial involves.

You may not be able to join if

  • I have trouble communicating due to aphasia.
  • I am confused and unable to understand.
  • I am not medically stable.
  • I cannot stand on my own.
  • I refuse to provide written informed consent.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging. 2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies. 3. Depressed patients will be included in the study 4. Patients able to…
Contacts

Meheroz H Rabadi, MD, MRCPI

405-456-5298

rabadimh@gmail.com

CONTACT